Diphtheria Completed Phase Trials for Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (DB10991)

Also known as: Corynebacterium diphtheriae infection / Infection due to Corynebacterium diphtheriae (disorder) / Diphtheria caused by Corynebacterium diphtheriae (disorder) / Diphtheria, unspecified

IndicationStatusPhase
DBCOND0000394 (Diphtheria)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02447978Duration of Protection: GSK DTaP Vaccines
NCT00908115Post Market Surveillance for Infanrix™
NCT00804284Database Surveillance Safety Study of PENTACEL® Vaccine
NCT00524732Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age
NCT00297856Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine
NCT00146835Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine